RxDoctor Payments Data

Stephanie Strout, PA

Medical · Overland Park, KSNPI 1487607453

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,253 of the $3,107 with a category attached, or 72.5%. 14 manufacturers reported payments, led by Medtronic at 45.0% of the total. Reporting peaked in 2024 at $1,756 and has fallen 77.3% since, to $398 in 2025.

$3,107in general payments, 2019–2025

Across 59 payments — averaging $52.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1K
  • Boston Scientific$843
  • Amgen$222
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$166
  • Novartis$140
  • E.r. Squibb & Sons, L.L.C.$103
  • plus $235 from 8 others

What the payments were for

  • Travel & lodging$85427%
  • Food & beverage$2,25373%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,107 in reported general payments places this provider in the 75th percentile of 205 medical providers in Kansas.

See all medical providers in Kansas

Medicare billing

Part B allowed, 2024
$20,640
Medicare patients
197
Services billed
236

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Repatha SureclickEvolocumab68$36,834
EliquisApixaban12$10,204
Praluent PenAlirocumab18$8,027
ClopidogrelClopidogrel Bisulfate98$1,393
Atorvastatin Calcium79$610
Carvedilol24$475
Rosuvastatin Calcium52$353
Ezetimibe18$325
Losartan Potassium28$280
Amlodipine Besylate22$264
Isosorbide Mononitrate ErIsosorbide Mononitrate27$196
Potassium Chloride19$124
Furosemide29$81
Spironolactone21$72

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$35$10,20412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 205 medical providers in Kansas.

Other medical in Overland Park

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →